Interview with Dan Brown , Managing Director, Genzyme Australia
What impact will the recent PBS reforms have on Genzyme’s operations in Australia? Genzyme is different in terms of its focus on rare & unmet medical needs, so most of…
Address: PO Box 196 Hawthorn Victoria 3122,Australia
Tel: +61 3 8823 7333
Web: http://www.servier.com.au/home/default.asp
Servier Australia is the local subsidiary of Servier, a leading French research-based pharmaceutical entity, specialising in ethical pharmaceuticals. Employing over 200 people in Australia, it recently moved to its new head office in Hawthorn, Melbourne. In 2006 Servier Australia had an annual turnover of over $136 million showing a growth of 9% from 2005. It is the ninth ranked subsidiary in the Servier Group and currently ranks within the top 15 largest pharmaceutical companies in Australia. Imminent new product launches will see it rise further up the rankings.
Cardiovascular, Osteoporosis, Diabetes
What impact will the recent PBS reforms have on Genzyme’s operations in Australia? Genzyme is different in terms of its focus on rare & unmet medical needs, so most of…
To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the national industry association for innovative pharmaceutical companies. . Just about every company engaged in…
Your distinguished career in health research leadership and management has seen you through a variety of prestigious positions, not to mention the Order of Australia. Most recently you were appointed…
Australia, the “land down under” to many Westerners, is sometimes left at just that — out of sight, and out of mind. But investors who ignore Australia do so…
See our Cookie Privacy Policy Here
